SEC Filing Details
Document Details
Form
Filing Date
May 3, 2017
Document Date
May 3, 2017
Form Description
Registration of up to an additional 20% of securities for an offering filed on an F-1
Filing Group
Registration Statements
Company
Urogen Pharma Inc.
Issuer
UroGen Pharma Ltd.